Malaria is caused not by a virus or bacterium, but by a complex, shape-shifting parasite that has evolved alongside us for millennia. This has made vaccine development a brutal challenge.
In this episode, Jacob and Saloni are joined by Katharine Collins, who co-invented the second malaria vaccine, called R21, during her PhD. They discuss the gruelling process of reverse-engineering a vaccine and eureka moments along the way. They ask whether the biggest barriers to new vaccines are scientific or financial, and what it will take to finally eradicate one of natureʼs most vicious killers.
Hard Drugs is a podcast from Works in Progress about medical innovation presented by Saloni Dattani and Jacob Trefethen.
Timestamps: 00:00 Introduction 05:08 Our favourite parasites 10:12 How to invent a vaccine during your PhD 34:18 Why is it called the R21 vaccine? 37:32 Moving from the bench to billions of doses 41:43 The vicious life cycle of malaria parasites 46:15 Malaria research IN MICE 53:03 The murderer in malaria research 55:51 Would you volunteer to get infected by malaria? 1:08:21 Why did the first malaria vaccine take so long? 1:18:26 Could we have had the vaccine sooner? 1:40:48 Vaccine versus vaccine: which one’s better? 1:46:53 If we did this again today, could we make better vaccines? 2:04:55 Conclusion and our reasons for pessimism and optimism
You can watch or listen on YouTube, Spotify, or Apple Podcasts.
Ernst R. Berndt, Rachel Glennerster, Michael R. Kremer, Jean Lee, Ruth Levine, Georg Weizsacker & Heidi Williams (2005) Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness. https://www.nber.org/papers/w11288
Podden och tillhörande omslagsbild på den här sidan tillhör
Saloni Dattani & Jacob Trefethen. Innehållet i podden är skapat av Saloni Dattani & Jacob Trefethen och inte av,
eller tillsammans med, Poddtoppen.